secwatch.observer — SEC 8-K summary
======================================

Issuer:     Serina Therapeutics, Inc. (SER)
CIK:        0001708599
Form:       8-K
Filed at:   2023-08-25T23:59:59+00:00
Accession:  0001493152-23-030212
Event type: debt
Sentiment:  neutral
Materiality: 0.50
Item codes: 2.03, 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AgeX Therapeutics draws $500k under secured note with Juvenescence
------------------------------------------------------------------

- Drew $500,000 under Amended and Restated Secured Convertible Promissory Note with Juvenescence Limited on August 22, 2023.
- Repayment date for outstanding principal is February 14, 2024.
- Terms previously summarized in May 12, 2023 10-Q and June 8, August 4, 2023 8-K filings.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1708599/000149315223030212/0001493152-23-030212-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1708599/000149315223030212/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-030212

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer